The global Gene Expression market was valued at USD 3.62 billion in 2016 and is projected to reach USD 8.03 billion by 2025, growing at a CAGR of 9.27% from 2017 to 2025.
With increasing applications of molecular biology and biotechnology in diagnosis and treatment of chronic diseases and genetic disorders, the use gene expression technologies and methods has also increased. The market is thus expected to grow in the near future.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Cost benefits and affordability regarding sequencing
1.2 Increasing prevalence of cancer
1.3 Available Govt. Fund
1.4 Usability in Aid Gene expression studies
1.5 Sbs Technology to Aid More Detailed Cancer Studies
1.6 Availability Of Gene Expression Databases due to expansion of bioinformatics
2. Market Restraints
2.1 High equip mentation cost
2.2 Lack of Trained professionals
Market Segmentation:
1. By Application:
1.1 Research
1.2 Drug Discovery
1.3 Diagnostics
1.4 Other Applications
2. By Service:
2.1 Gene Expression Profiling Services
2.1.1 Sequencing Services
2.1.2 Other Services
2.2 Bioinformatics Solutions
3. By Technology:
3.1 Polymerase Chain Reaction (PCR)
3.2 Next-Generation Sequencing (NGS)
3.2.1 Cost and Speed Of NGS
3.2.2 Substitution Of Microarray Technology By NGS
3.2.3 Research Laboratories and Academicians Promoting NGS
3.2.4 Global Alliances Among Leading Research Institutes to Assist Drug Discovery and Increase theDemand for NGS
3.3 Dna Microarray
3.4 Others
3.4.1 Serial Analysis Of Gene Expression
3.4.2 Northern Blotting
4. By Consumables:
4.1 Reagents
4.2 Dna Chips
5. By Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific, Inc.
2. Qiagen N.V.
3. Illumina, Inc.
4. Bio-Rad Laboratories, Inc.
5. F. Hoffmann-La Roche Ltd. (Roche)
6. Agilent Technologies, Inc.
7. Affymetrix, Inc.
8. GE Healthcare
9. Perkinelmer, Inc.
10. Oxford Gene Technology
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Gene Expressionmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL GENE EXPRESSIONMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL GENE EXPRESSIONMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL GENE EXPRESSION MARKET, BY APPLICATION:
5.1 Research
5.2 Drug Discovery
5.3 Diagnostics
5.4 Other Applications
6 GLOBAL GENE EXPRESSION MARKET, BY SERVICE:
6.1 Gene Expression Profiling Services
6.1.1 Sequencing Services
6.1.2 Other Services
6.2 Bioinformatics Solutions
7 GLOBAL GENE EXPRESSION MARKET, BY TECHNOLOGY:
7.1 Polymerase Chain Reaction (PCR)
7.2 Next-Generation Sequencing (NGS)
7.2.1 Cost and Speed Of NGS
7.2.2 Substitution Of Microarray Technology By NGS
7.2.3 Research Laboratories and Academicians Promoting NGS
7.2.4 Global Alliances Among Leading Research Institutes to Assist Drug Discovery and Increase theDemand for NGS
7.3 Dna Microarray
7.4 Others
7.4.1 Serial Analysis Of Gene Expression
7.4.2 Northern Blotting
8 GLOBAL GENE EXPRESSION MARKET, BY CONSUMABLES:
8.1 Reagents
8.2 Dna Chips
9 GLOBAL GENE EXPRESSIONMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL GENE EXPRESSIONMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Qiagen N.V.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Illumina, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 F. Hoffmann-La Roche Ltd. (Roche)
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Agilent Technologies, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Affymetrix, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 GE Healthcare
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Perkinelmer, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development
11.10 Oxford Gene Technology
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development
12 Appendix
12.1 Related Reports
The Gene Knockdown Stable Cell Line Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Gene Knockdown Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...
The Gene Editing Technology Innovation Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Cell and Gene Therapy Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Microbial Gene Editing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Specialized Logistics For Cell and Gene Therapies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competit...
The Custom Gene Synthesis Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
The Cell And Gene Therapy Manufacturing Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...
The Gene Modification Production Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Gene Editing Manufacturing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...